A detailed history of Intech Investment Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 147,348 shares of IOVA stock, worth $528,979. This represents 0.01% of its overall portfolio holdings.

Number of Shares
147,348
Previous 97,958 50.42%
Holding current value
$528,979
Previous $919,000 18.61%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$7.17 - $12.28 $354,126 - $606,509
49,390 Added 50.42%
147,348 $1.09 Million
Q3 2024

Nov 08, 2024

BUY
$7.28 - $11.9 $713,134 - $1.17 Million
97,958 New
97,958 $919,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $567M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.